Altimmune, Inc.·4

Mar 9, 7:00 AM ET

Durso Jerome Benedict 4

Research Summary

AI-generated summary

Updated

Altimmune (ALT) CEO Jerome Durso Buys 20,000 Shares

What Happened

  • Durso Jerome Benedict (President, CEO and Director) purchased 20,000 shares of Altimmune, Inc. in open-market transactions on March 6, 2026. The weighted average price reported was $3.54 per share, for a total transaction value of approximately $70,790. This is a purchase (code P).

Key Details

  • Transaction date: 2026-03-06; Form 4 filed: 2026-03-09 (appears timely under the two-business-day rule).
  • Price: weighted average $3.54; reported price range across multiple trades $3.5300–$3.5500 (see footnote F1).
  • Total shares acquired: 20,000; total value ≈ $70,790.
  • Shares owned after the transaction: not specified in this filing.
  • Footnote: F1 states the $3.54 is a weighted average and the reporter will provide the per-price breakdown on request.

Context

  • Open-market purchases by executives are often noted by investors as informative, but the filing does not state the insider’s motivation. No options were exercised and no awards, gifts, or tax-withholding actions are involved in this report.